Preoperative radiation therapy for locally advanced rectal cancer: a comparison between two different time intervals to surgery

被引:36
|
作者
Veenhof, A. A. F. A.
Kropman, R. H. J.
Engel, A. F.
Craanen, M. E.
Meijer, S.
Meijer, O. W. M.
van der Peet, D. L.
Cuesta, M. A.
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Surg, NL-1007 MB Amsterdam, Netherlands
[2] Zaans Med Ctr, Dept Surg, Zaandam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol, NL-1007 MB Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Radiat Oncol, NL-1007 MB Amsterdam, Netherlands
关键词
radiation therapy; interval; rectal cancer; total mesorectal excision; cancer;
D O I
10.1007/s00384-006-0195-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Although it is now considered a standard treatment to irradiate an advanced mid or low rectal tumor before surgical total mesorectal excision (TME), the optimal time interval between radiation therapy and surgery remains controversial. Materials and methods Between 1995 and 2005, patients undergoing preoperative radiation therapy and TME for locally advanced mid and low rectal tumors treated in the VU Medical Center or the Zaans Medical Center were entered into this study. All patients received identical radiation treatment in the VU Medical Center and were subsequently operated on within 2 weeks in the Zaans Medical Center (SI group) and after 6-8 weeks in the VU Medical Center (LI group). Preoperative tumor staging, operative data, postoperative complications, pathology results, and follow-up were compared. Results The SI group (N=57) underwent surgery after a median delay of 4 days and the LI group (N=51) after 45 days. Operative data and short-term morbidity were comparable for both groups. However, significantly higher numbers of complete remissions (12 vs 0%), tumor downstaging (55 vs 26%), and less lymph-node metastases (22 vs 44%) were found in the LI group. No significant differences were found regarding local control or long-term survival after a median follow-up of 34 months. Conclusion Several advantages, such as complete remissions and downstaging in the LI group, do not appear to have expression in a better survival or less local recurrences after a median follow-up of 34 months. Although larger (randomized) studies will be needed for definite conclusions, this may indicate that patients can be operated on within 2 weeks after radiation therapy.
引用
收藏
页码:507 / 513
页数:7
相关论文
共 50 条
  • [21] Preoperative chemoradiotherapy for locally advanced rectal cancer
    Ronzoni, M.
    Vitali, G.
    Tamburini, A. M.
    Staudacher, C.
    Villa, E.
    ANNALS OF ONCOLOGY, 2005, 16 : 44 - 44
  • [22] Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers
    Lim, Seok-Byung
    Choi, Hyo Seong
    Jeong, Seung-Yong
    Kim, Dae Yong
    Jung, Kyung Hae
    Hong, Yong Sang
    Chang, Hee Jin
    Park, Jae-Gahb
    ANNALS OF SURGERY, 2008, 248 (02) : 243 - 251
  • [23] Preoperative chemoradiotherapy in locally advanced rectal cancer
    Molinaro, MA
    ANNALS OF ONCOLOGY, 2005, 16 : 287 - 288
  • [24] SURGICAL COMPLICATIONS FOR LOCAL ADVANCED RECTAL CANCER - COMPARISON OF TWO DIFFERENT PREOPERATIVE CHEMOTHERAPIES
    Gu, J.
    Zhang, X.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E281 - E282
  • [25] Prognostic factors after preoperative irradiation and surgery for locally advanced rectal cancer
    Larsen, S. G.
    Wiig, J. N.
    Dueland, S.
    Giercksky, K. -E.
    EJSO, 2008, 34 (04): : 410 - 417
  • [26] Comparison of Hypofractionated and Conventional Preoperative Radiotherapy for Locally Advanced Rectal Cancer in the Elderly
    Guillerme, F.
    Kurtz, J. E.
    Clavier, J. B.
    Guihard, S.
    Schumacher, C.
    Jung, G. M.
    Brigand, C.
    Meyer, C.
    Rohr, S.
    Noel, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S365 - S365
  • [27] Irinotecan in preoperative combined-modality therapy for locally advanced rectal cancer
    Mitchell, EP
    ONCOLOGY-NEW YORK, 2000, 14 (12): : 56 - 59
  • [28] Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer:: a multicentric phase II study
    De Paoli, A
    Chiara, S
    Luppi, G
    Friso, ML
    Beretta, GD
    Del Prete, S
    Pasetto, L
    Santantonio, M
    Sarti, E
    Mantello, G
    Innocente, R
    Frustaci, S
    Corvò, R
    Rosso, R
    ANNALS OF ONCOLOGY, 2006, 17 (02) : 246 - 251
  • [29] Phase I trial of preoperative cetuximab in combination with oxaliplatin, capecitabine, and radiation therapy for locally advanced rectal cancer
    Cabebe, E. C.
    Kuo, T.
    Koong, A.
    Welton, M.
    Shelton, A.
    Kunz, P. L.
    Ford, J. M.
    Sikic, B. I.
    Kaiser, H. L.
    Rogers, J.
    Fisher, G. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Optimal time interval between capecitabine intake and radiotherapy in preoperative chemoradiation for locally advanced rectal cancer
    Yu, Chang Sik
    Kim, Tae Won
    Kim, Jong Hoon
    Choi, Won Sik
    Kim, Hee Cheol
    Chang, Heung Moon
    Ryu, Min Hee
    Jang, Se Jin
    Do Ahn, Seung
    Lee, Sang-wook
    Shin, Seong Soo
    Choi, Eun Kyung
    Kim, Jin Cheon
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (04): : 1020 - 1026